期刊文献+

紫杉醇联合顺铂化疗治疗宫颈癌的临床护理体会 被引量:1

Clinical Nursing Experience of Paclitaxel Combined With Cisplatin in the Treatment of Cervical Cancer
下载PDF
导出
摘要 目的探讨紫杉醇联合顺铂化疗治疗宫颈癌的临床护理体会。方法本次研究对象来源于我院妇科2015年9月—2016年9月收治的宫颈癌患者76例,随机分成两组,各38例,对照组采用常规护理,观察组采用综合护理,比较两组护理效果。结果两组干预前SAS、SDS评分比较差异无统计学意义(P>0.05),干预后观察组SAS、SDS评分均低于对照组及本组治疗前(P<0.05)。结论紫杉醇联合顺铂治疗宫颈癌与护理措施联合使用效果优良。 Objective To explore the clinical nursing experience of paclitaxel combined with cisplatin in the treatment of cervical cancer. Methods The subjects of this study were from 76 cases of cervical cancer treated in our hospital from September 2015 to September 2016. They were randomly divided into two groups, 38 cases each, the control group was treated with routine nursing, and the observation group was treated with comprehensive nursing. The nursing effects of the two groups were compared. Results There was no significant difference between the two groups in the scores of SAS and SDS before intervention (P 〉 0.05), after the intervention, the scores of SAS and SDS in the observation group were lower than those in the control group and before the treatment (P 〈 0.05). Conclusion Paclitaxel combined with cisplatin in the treatment of cervical cancer and nursing measures combined with good results.
作者 卫素青
出处 《中国卫生标准管理》 2017年第12期165-167,共3页 China Health Standard Management
关键词 紫杉醇 顺铂 宫颈炎 护理体会 paclitaxel cisplatin cervicitis nursing experience
  • 相关文献

参考文献9

二级参考文献37

  • 1陆宇晗,尤黎明,马双莲,郭美珠,张荔,闻利红.癌症疼痛患者对疼痛治疗的顾虑与遵医行为[J].中国疼痛医学杂志,2004,10(6):335-337. 被引量:37
  • 2陆红霞,徐丛剑,李斌.紫杉醇剂型、临床用药方式及联合用药的研究进展[J].国外医学(药学分册),2005,32(2):73-77. 被引量:11
  • 3Chen XS, Nie XQ, Chen CM, et al. Weekly paclitaxel plus carbo- platin is an effective nonanthraeyeline -containing regimen as neo- adjuvant chemotherapy for brease cancer[ J]. Ann Oncol, 2010,21 (5) :961-967.
  • 4Yeo KO, Hyun JL, Mi-Hee J, et al. Role of activating transcrip- tion factor 3 on tap73 stability and apoptosis in paclitaxel treated cervical cancer cells [ J ]. Molecular Cancer Research, 2008,6 (7) :1232-1249.
  • 5Kuh HJ, Jang SH, Wientjes MG, et al. Computational model of intracellular pharmacokinetics of paclitaxel [ J ]. J Pharmacol Exp Ther, 2000,293(3) :761-770.
  • 6Mori T, Kinoshita Y, Watanabe A, et al. Retention of paclitaxel in cancer ceils for 1 week in vivo and in vitro [ J ]. Cancer Che- mother Pharmacol, 2006,58 (5) :665-672.
  • 7Sehouli J, Stengel D, Mustea A. Weekly paclitaxel and carboplatin for patients with primary advanced ovarian cancer: results of a mul- ticenter phase-II study of the NOGGO [ J ]. Cancer Chemother Pharmaeol, 2008,61 (2) :243-250.
  • 8Gianni L, Kearns CM, Gianni A, et al. Nonlinear pharmaeokinet- ies and metabolism of paclitaxel and its pharmaeokinetic/ pharma- eodynamie relationships in humans[J]. J Clin Oneol, 1995, 13 ( 1 ) : 180-190.
  • 9Moil T, Hosokawa K, Kinoshita Y, et al. Neoasjuvant chemother- apy with weekly earboplatin and paelitaxel for locally advanced cer- vical carcinoma[ J]. Int J Gynecol Cancer, 2008, 18 ( 1 ) :85-89.
  • 10Portelance I,Chao KS,Crigsby PW,et al.Intensity-modulated radiation therapy reduces small bowel,rectum,and bladder doses in patients with cervical cancer receiving pelvic and paraaortic irradiation[J].Int J Radiat Oncol Biol Phys,2001,51(1):261-266.

共引文献73

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部